Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-11203.66% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ONCO · Jun 30, 2026
Onconetix, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001213900-26-089093General Corporate
Evidence method
Yoy · gp.fundamentals.revenue
-83.92% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
1229.25% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
25.13% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-15950.88% · CORE · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
42.98% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History11 statesHistory building
Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/6 normalizedLevel 3Sep 30, 20240/7 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/7 normalizedLevel 3Jun 30, 20250/6 normalizedLevel 3Sep 30, 20250/6 normalizedLevel 3Dec 31, 20255/6 normalizedLevel 3Mar 31, 20265/6 normalizedLevel 3Jun 30, 20265/6 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- -9887.13%
- Current
- -11203.66%
- Delta
- -1316.53%
- Previous
- -78.89%
- Current
- -83.92%
- Delta
- -5.04%
- Previous
- 641.48%
- Current
- 1229.25%
- Delta
- 587.77%
- Previous
- -7.71%
- Current
- 25.13%
- Delta
- 32.85%
- Previous
- -47657.18%
- Current
- -15950.88%
- Delta
- 31706.30%
- Previous
- 103.95%
- Current
- 42.98%
- Delta
- -60.97%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Pharmaceutical Preparations peers →Has State · Onconetix, Inc. →Transitioned To · ONCO Fundamental State →Transitioned To · ONCO CASH_GENERATION_DECREASED →Transitioned To · ONCO GROWTH_DECREASED →Transitioned To · ONCO INVENTORY_PRESSURE_INCREASED →Transitioned To · ONCO MARGIN_INCREASED →Transitioned To · ONCO PROFITABILITY_INCREASED →Transitioned To · ONCO SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.